Keyphrases
COVID-19
100%
Multiple Sclerosis
68%
New York City
56%
Neurology
50%
Comprehensive Care Centre
25%
Hospitalized Patients
25%
Neuroeducation
25%
Neurologic Disorders
25%
Neurology Services
25%
Th17 Cytokines
25%
Training Program
25%
Tumor Necrosis Factor Antagonist
25%
Safety-net Hospital
25%
Multi-ethnic
25%
Multiple Sclerosis Treatment
25%
Neurological Deficit
25%
High-dose Cyclophosphamide
25%
Tumor Necrosis Factor-α
25%
Calpain
25%
Gene Expression
25%
Peripheral Blood Mononuclear Cells
25%
Marburg
25%
Cyclophosphamide Treatment
25%
Calpain Inhibition
18%
Interpersonal Support
12%
Team Structure
12%
Support Mechanisms
12%
Hospital Expansion
12%
Patients with COVID-19
12%
Lieu
12%
City Hospitals
12%
Supervisory Support
12%
Tertiary Care Hospital
12%
Internal Medicine
12%
T Helper 17 (Th17)
12%
COVID-19 Pandemic
12%
Brooklyn
12%
Multiethnic Community
12%
Redeployment
12%
Related Disorders
10%
Disease-modifying Therapy
10%
Critical Illness
10%
In-hospital Mortality
8%
Reaction Probability
8%
Adverse Drug Reaction
8%
In-hospital Outcomes
6%
Laboratory Confirmation
6%
Outpatient Services
6%
Education Curriculum
6%
Teamwork
6%
Medicine and Dentistry
COVID-19
100%
Neurology
50%
Multiple Sclerosis
50%
Observational Study
28%
Neurologic Disease
28%
Flexibility
25%
Tumor Necrosis Factor
25%
Prospective Study
25%
Drug Megadose
25%
Cyclophosphamide
25%
Disease
19%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Division
12%
Disease Modifying Therapy
9%
Hospital Mortality
9%
Critical Illness
9%
Infection
9%
Polyneuropathy
7%
Adverse Drug Reaction
7%
Internal Medicine
6%
Medicine
6%
Continuity Clinics
6%
Intensive Care Unit
6%
Outpatient
6%
Tertiary Care
6%
Symptom
6%
Hazard Ratio
6%
Social Distancing
6%
Prevalence
6%
Pandemic
6%
SOFA Score
6%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Sclerosis
75%
Disease
65%
Coronavirinae
50%
Observational Study
27%
Neurologic Disease
26%
Tumor Necrosis Factor
25%
Cyclophosphamide
25%
Cytokine
25%
Calpain
25%
Prospective Study
25%
SARS Coronavirus
11%
Hospital Mortality
8%
Infection
7%
Adverse Drug Reaction
7%
Polyneuropathy
7%
Prevalence
5%
Organ Dysfunction Score
5%
Critical Illness
5%